Stock Information
MapLight Therapeutics Inc (MPLT)
Ticker Symbol: MPLT
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $960.55 mil
Piotroski score: 2
Financial data not available
Latest News
-
MapLight Therapeutics Completes Enrollment In Its Phase 2 Zephyr Trial Evaluating Ml-007C-MA For The Treatment Of Schizophrenia
Fri, May 1, 2026 7:06 AM
-
MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results
Fri, May 1, 2026 7:00 AM
Key Financials
Financial data not available
